These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 37288246)

  • 41. Roles of Long Non-coding RNAs in the Development of Aging-Related Neurodegenerative Diseases.
    Ni YQ; Xu H; Liu YS
    Front Mol Neurosci; 2022; 15():844193. PubMed ID: 35359573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain functional network modeling and analysis based on fMRI: a systematic review.
    Wang Z; Xin J; Wang Z; Yao Y; Zhao Y; Qian W
    Cogn Neurodyn; 2021 Jun; 15(3):389-403. PubMed ID: 34040667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases.
    Zheng Q; Huang T; Zhang L; Zhou Y; Luo H; Xu H; Wang X
    Front Aging Neurosci; 2016; 8():303. PubMed ID: 28018215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tracers progress for positron emission tomography imaging of glial-related disease.
    Jia H; Xie T
    J Biomed Res; 2022 Jun; 36(5):321-335. PubMed ID: 36131689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
    Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Neurovascular System in Neurodegenerative Diseases.
    Ahmad A; Patel V; Xiao J; Khan MM
    Mol Neurobiol; 2020 Nov; 57(11):4373-4393. PubMed ID: 32725516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modelling neurodegenerative diseases with 3D brain organoids.
    Chang Y; Kim J; Park H; Choi H; Kim J
    Biol Rev Camb Philos Soc; 2020 Oct; 95(5):1497-1509. PubMed ID: 32568450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetically modified pig models for neurodegenerative disorders.
    Holm IE; Alstrup AK; Luo Y
    J Pathol; 2016 Jan; 238(2):267-87. PubMed ID: 26446984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AMPK-mediated regulation of neuronal metabolism and function in brain diseases.
    Liu YJ; Chern Y
    J Neurogenet; 2015; 29(2-3):50-8. PubMed ID: 26119401
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases.
    Pillon B; Deweer B; Agid Y; Dubois B
    Arch Neurol; 1993 Apr; 50(4):374-9. PubMed ID: 8460958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurodegenerative movement disorders: the contribution of functional imaging.
    Piccini P
    Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of Nanomaterials in Neurodegenerative Diseases.
    Cui W; Fu W; Lin Y; Zhang T
    Curr Stem Cell Res Ther; 2021; 16(1):83-94. PubMed ID: 32213159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders.
    Liu J; Duan W; Deng Y; Zhang Q; Li R; Long J; Ahmed W; Gu C; Qiu Y; Cai H; Hu Y; Chen L
    J Integr Neurosci; 2023 May; 22(3):58. PubMed ID: 37258447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroepigenetics of Aging and Age-Related Neurodegenerative Disorders.
    Lardenoije R; Pishva E; Lunnon K; van den Hove DL
    Prog Mol Biol Transl Sci; 2018; 158():49-82. PubMed ID: 30072060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw.
    Spires TL; Hannan AJ
    FEBS J; 2005 May; 272(10):2347-61. PubMed ID: 15885086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular diagnostics of neurodegenerative disorders.
    Agrawal M; Biswas A
    Front Mol Biosci; 2015; 2():54. PubMed ID: 26442283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review.
    Yang X; Ma Z; Lian P; Xu Y; Cao X
    Front Mol Neurosci; 2023; 16():1172197. PubMed ID: 37168679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
    Sivagurunathan N; Ambatt ATS; Calivarathan L
    Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffusion-MRI in neurodegenerative disorders.
    Goveas J; O'Dwyer L; Mascalchi M; Cosottini M; Diciotti S; De Santis S; Passamonti L; Tessa C; Toschi N; Giannelli M
    Magn Reson Imaging; 2015 Sep; 33(7):853-76. PubMed ID: 25917917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases.
    Duarte-Neves J; Pereira de Almeida L; Cavadas C
    Neurobiol Dis; 2016 Nov; 95():210-24. PubMed ID: 27461050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.